Bextra
Bextra Side Effects May Link To False Claims Lawsuits
Bextra Side Effects Injury Lawsuits. On April 7, 2005, the FDA and European regulators formally asked Pfizer to suspend sales of Bextra in the United States and Europe. As a result, Pfizer announced it would halt sales of the drug in the United States and the European Union countries immediately. The FDA stated that the … [Read more...] about Bextra Side Effects May Link To False Claims Lawsuits
Big Fine Over Bextra Promotion
Pfizer to Pay Big Fine. Drug maker Pfizer, Inc. led the news with two announcements this week: It took a record-breaking hit of $2.3 billion over investigations into its improper marketing of the painkiller Bextra and other medications and it is acquiring its rival, Wyeth, for $68 billion, reported Bloomberg … [Read more...] about Big Fine Over Bextra Promotion
Arizona Bextra Lawsuit Charges Pfizer
Arizona Bextra Lawsuit Charges Pfizer In 2005, the U.S. Food and Drug Administration (FDA) and European regulators formally asked Pfizer, Inc. to suspend sales of Bextra in the United States and Europe. As a result, Pfizer announced it would halt sales of the drug in the United States and the European Union countries immediately. The … [Read more...] about Arizona Bextra Lawsuit Charges Pfizer
Pfizer Bextra, Celebrex Settlement
Pfizer Bextra, Celebrex Settlement. Pfizer has reached a tentative agreement to settle lawsuits involving its Bextra and Celebrex painkillers for $894 million. If it goes forward, the Pfizer Bextra and Celebrex settlement will resolve roughly 90 percent of the personal injury lawsuits the company faces because of the … [Read more...] about Pfizer Bextra, Celebrex Settlement
Celebrex, Bextra Settlements Negotiation
Pfizer Celebrex, Bextra Settlements. Celebrex and Bextra maker Pfizer Inc. has begun to settle injury claims against the painkillers. It is estimated that between 7,000 and 9,000 Celebrex and Bextra cases have been filed by people who claim the defective painkillers caused heart attacks and strokes. According to a report in Friday's … [Read more...] about Celebrex, Bextra Settlements Negotiation
Pfizer Obstructing Off-label Marketing Probe
Pfizer Off-label Marketing Probe. An investigation of Pfizer Inc. drug marketing efforts has resulted in charges being filed against a former Pfizer sales manager. The four count indictment alleges that the former Pfizer employee tried to obstruct an investigation into possible off-label marketing of some ‘Pfizer’ … [Read more...] about Pfizer Obstructing Off-label Marketing Probe
Life-Threatening Bextra Side Effects
Bextra Side Effects Injury Lawsuits. Pfizer Inc.'s pain pill Bextra should be kept off the market permanently because of potentially life-threatening side effects, federal regulators said Wednesday. Food and Drug Administration staff members concluded that the drug has greater health risks than similar painkillers, including … [Read more...] about Life-Threatening Bextra Side Effects
Health Canada Bans Bextra Sales
Pfizer's Bextra Was Removed From The Market. The era of the COX-2 inhibitors appears to be coming to an end. Vioxx was removed from the market worldwide by Merck in September 2004. Pfizer has announced Celebrex is about to undergo new safety testing while the company’s other COX-2 inhibitor, Bextra, was removed from the market in … [Read more...] about Health Canada Bans Bextra Sales
SEC Asks For Pfizer Documents
Pfizer Painkillers Documents. Pfizer Inc., the world's biggest drugmaker, said the Securities and Exchange Commission has requested documents about its Cox-2 class of painkillers. In its quarterly filing submitted to the regulator today, the company didn't say when the SEC made its request. New York-based Pfizer earlier received a … [Read more...] about SEC Asks For Pfizer Documents
FDA Bans Bextra Painkiller Sale
Bextra Risk Of Heart Attack And Skin Conditions. The Food and Drug Administration has followed the US FDA's lead by banning the sale of Bextra, a kind of painkiller for joint aches which puts users at risk of heart attack and skin conditions. The US FDA on April 7 asked Pfizer to withdraw ‘Bextra’ from the market and announced … [Read more...] about FDA Bans Bextra Painkiller Sale
Pfizer Pulls Bextra From UAE
Pfizer Pulls Bextra. Pfizer has decided to also follow the US Food and Drug Administration ruling in the United Arab Emirates and withdraw its painkiller Bextra. Risks To The Heart And Stomach The company still hopes that the drug may be re-introduced but the FDA said its risks to the heart and stomach outweighed potential … [Read more...] about Pfizer Pulls Bextra From UAE
Bextra: More Risks Than Benefits
Bextra May Cause Heart Attacks And Strokes. The Food and Drug Administration has asked pharmaceutical company Pfizer to pull Bextra off the market because of evidence that it increases the risk of heart attacks, strokes and a potentially fatal skin condition as well. The Early Show medical correspondent Dr. Emily Senay explains … [Read more...] about Bextra: More Risks Than Benefits
Bextra Taken Off Market
Pfizer Inc. reluctantly halted sales of its arthritis painkiller Bextra on Thursday after the Food and Drug Administration concluded that it posed too many serious safety risks. It was the second major arthritis medication to be withdrawn in the last six months. In addition to asking Pfizer to stop selling its $1.4 billion-a-year … [Read more...] about Bextra Taken Off Market
HSA Suspends Bextra Sales in Singapore
Pfizer’s Bextra Banned In Singapore. Singapore has suspended the sales of ‘Bextra’, an anti-inflammatory drug produced by the global pharmaceutical manufacturer Pfizer. Study shows that taking ‘Bextra’ may pose risk to patients' cardiovascular safety or incur rare but serious skin reactions, which have led to similar bans on the … [Read more...] about HSA Suspends Bextra Sales in Singapore
Pfizer Pulls Bextra
First, though, there is important medical news that you need to know about. The drugmaker Pfizer is pulling its arthritis painkiller Bextra off the market. The Food and Drug Administration asked for the recall. The FDA also called for the strongest possible warning on Pfizer's other big arthritis painkiller, Celebrex. Our medical … [Read more...] about Pfizer Pulls Bextra
Pfizer Halts Sales of Bextra
Bextra Risks Outweigh Its Benefits. Pfizer has agreed to stop selling Bextra, a popular arthritis drug, the Food and Drug Administration announced Thursday, because the FDA believes its risks outweigh its benefits. The FDA will also now require a black box warning the strongest type of warning on the labels of Pfizer's blockbuster … [Read more...] about Pfizer Halts Sales of Bextra
FDA Tells Pfizer To Pull Bextra Off Market
Bextra Black Box Warning. Food and Drug Administration officials Thursday told Pfizer Inc. to take its COX-2 drug Bextra off the U.S. market and put a warning on Celebrex. The FDA, based on recommendations from its Arthritis and Drug Safety and Risk Management Advisory Committee following a hearing in February, also asked … [Read more...] about FDA Tells Pfizer To Pull Bextra Off Market
Study: 3 Painkillers’ Heart Risk
Painkillers' Heart Risk. A new study has linked painkillers Vioxx, Celebrex and Bextra to increased cardiovascular risk, reinforcing findings of other trials that have already sparked concern over the safety of a popular category of drugs. Vioxx and Celebrex increased patients' risk of heart attack and stroke by about 20 percent … [Read more...] about Study: 3 Painkillers’ Heart Risk
HMO Bans Bextra Until Safety is Proven
Heart Risks Associated With Bextra. Kaiser Permanente, the nation's largest not-for-profit managed-care provider, has stopped prescribing Bextra until tests show whether the painkiller is safe. The decision came amid "compelling" evidence of heightened heart risks associated with Bextra and a similar drug called Vioxx that … [Read more...] about HMO Bans Bextra Until Safety is Proven
Studies Expand Warnings on Painkillers
Painkillers Risk Of Heart Attacks And Strokes. Two studies released today have turned up new evidence that all of the popular arthritis painkillers known as COX-2 inhibitors may put users at greater risk of heart attacks and strokes. The first of the two papers published online by the journal Circulation found that patients who … [Read more...] about Studies Expand Warnings on Painkillers
EMEA Statement On Valdecoxib & Parecoxib Sodium
Valdecoxib New Safety Information. Cardiovascular Risks In Coronary Artery Bypass Graft (Cabg) Surgery And Serious Adverse Skin Reactions. The European Medicines Agency (EMEA) and its Scientific Committee for human medicines have been made aware of new safety information on cardiovascular and serious skin adverse events in relation … [Read more...] about EMEA Statement On Valdecoxib & Parecoxib Sodium
Suit Charging Bextra was Responsible for Cardiac Death
Bextra Blamed For Cardiac Death. Parker & Waichman, LLP and Seeger Weiss LLP have filed a case in Supreme Court of the State of New York, County of New York against Pfizer, Inc (NYSE:PFE). The case is on behalf of the estate of a 46 year old New Jersey resident who died of a heart attack after using ‘Bextra’. The suit … [Read more...] about Suit Charging Bextra was Responsible for Cardiac Death
Group Sues Pharmacia Over Drug Promotion
Pharmacia Illegal Drug Promotion. A consumer group sued Pharmacia Corp. over its promotion of the pain drug Bextra, alleging that the pharmaceutical company is circumventing federal marketing regulations. The Congress of California Seniors filed the suit in California Superior Court in Los Angeles on Monday, alleging that … [Read more...] about Group Sues Pharmacia Over Drug Promotion
Improper Pharmacia Marketing
Pharmacia Corp. Improper Marketing. A consumer group sued Pharmacia Corp. over its promotion of the pain drug Bextra, alleging that the pharmaceutical company is circumventing federal marketing regulations. The Congress of California Seniors filed the suit in California Superior Court in Los Angeles on Monday, alleging … [Read more...] about Improper Pharmacia Marketing
FDA, Pharmacia Update Bextra Label W/ New Warnings
Bextra Label New Warnings. FDA and Pharmacia are advising health care professionals about new warnings and information in the product labeling of the drug Bextra (valdecoxib), a drug approved for treatment of osteoarthritis, rheumatoid arthritis and dysmenorrhea (menstrual pain). The labeling is being updated with new warnings … [Read more...] about FDA, Pharmacia Update Bextra Label W/ New Warnings
